# Assessment of Plasma and NGAL for the Early Prediction of Acute Kidney Injury After Cardiac Surgery in Adults Study

> **NCT02733328** · — · COMPLETED · sponsor: **The Royal Wolverhampton Hospitals NHS Trust** · enrollment: 405 (actual)

## Conditions studied

- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- End Stage Renal Disease (ESRD)
- Estimated Glomerular Filtration Rate (eGFR)
- Neutrophil Gelatinase-associated Lipocalin (NGAL)
- Serum Creatinine (SCr)
- Urine Creatinine (UCr)
- Urine Albumin (UAlb)

## Interventions

- **PROCEDURE:** CPB Surgery

## Key facts

- **NCT ID:** NCT02733328
- **Lead sponsor:** The Royal Wolverhampton Hospitals NHS Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2018-11-17
- **Final completion:** 2020-09-07
- **Target enrollment:** 405 (ACTUAL)
- **Last updated:** 2025-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02733328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02733328, "Assessment of Plasma and NGAL for the Early Prediction of Acute Kidney Injury After Cardiac Surgery in Adults Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02733328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*